2023
DOI: 10.1111/cts.13570
|View full text |Cite
|
Sign up to set email alerts
|

Areas of strength and opportunities for growth in translational science education and training: Results of a scoping review from the NCATS Education Branch

Abstract: Translational science education and training (E&T) aims to prepare the translational workforce to accelerate progress along the translational pipeline toward solutions that improve human health. In 2020–2021, the National Center for Advancing Translational Sciences (NCATS) Education Branch conducted a scoping review of the E&T literature with this focus. The review used the methodological framework proposed by Arksey and O'Malley. PubMed, Education Resources Information Center (ERIC), and Embase were s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 68 publications
0
1
0
Order By: Relevance
“…The term emerged around 1990(11), gained prominence in 2008 (12), and peaked at the end of the last decade(13,14, 15). During the pandemic, it gained further notoriety, highlighting the urgent need to invest in education and training to build a diverse and highly qualified translational scientific workforce to overcome these challenges(16,17, 18,19,20).According to Sun et al (21), "Ninety percent of clinical drug development fails despite implementation of many successful strategies, which raised the question as to whether certain aspects in target validation and drug optimization are overlooked". This became evident in the early 2000s when Batta et al (22) verified the approval by the Center for Drug Evaluation and Research (CDER) -a division of the Food and Drug Administration…”
mentioning
confidence: 99%
“…The term emerged around 1990(11), gained prominence in 2008 (12), and peaked at the end of the last decade(13,14, 15). During the pandemic, it gained further notoriety, highlighting the urgent need to invest in education and training to build a diverse and highly qualified translational scientific workforce to overcome these challenges(16,17, 18,19,20).According to Sun et al (21), "Ninety percent of clinical drug development fails despite implementation of many successful strategies, which raised the question as to whether certain aspects in target validation and drug optimization are overlooked". This became evident in the early 2000s when Batta et al (22) verified the approval by the Center for Drug Evaluation and Research (CDER) -a division of the Food and Drug Administration…”
mentioning
confidence: 99%